Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7312 p235
14 August 2004


Society summary


President to serve on CHRE

It was agreed at the August Council meeting that the President of the day should be the Society’s representative on the Council for Healthcare Regulatory Excellence.

The Council was advised that the CHRE expects regulatory bodies to nominate their presidents to serve. Although appointments are for a renewable period of four years, the regulations enable a CHRE member to resign at any time, thus allowing a change of representative whenever a regulatory body has a change of president.

Back to Top


©The Pharmaceutical Journal